Using phospho-profiling, genetic, and biochemical approaches, our studies unravel a chemotherapy-induced mechanism for JAK1/STAT6/GAS6-mediated autocrine or paracrine signaling contributing to Ewing sarcoma chemoresistance, by activating TAM kinases and subsequent downstream Akt and ERK signaling. This evidence concerns the gene JAK1 and Ewing sarcoma.